Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.54 USD
Change Today +0.10 / 1.84%
Volume 173.6K
CO On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

china cord blood corp (CO) Snapshot

Open
$5.45
Previous Close
$5.44
Day High
$5.59
Day Low
$5.45
52 Week High
04/24/15 - $7.24
52 Week Low
12/15/14 - $4.10
Market Cap
443.7M
Average Volume 10 Days
183.3K
EPS TTM
$0.23
Shares Outstanding
80.1M
EX-Date
--
P/E TM
24.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA CORD BLOOD CORP (CO)

china cord blood corp (CO) Related Businessweek News

No Related Businessweek News Found

china cord blood corp (CO) Details

China Cord Blood Corporation, together with its subsidiaries, primarily provides umbilical cord blood storage and ancillary services in the People’s Republic of China. The company provides cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as offers matching services. As of March 31, 2015, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company has a strategic collaboration with Cord Blood Registry to share data on cord blood collection, processing, and storage. China Cord Blood Corporation is based in Central, Hong Kong.

china cord blood corp (CO) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: $345.8K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $345.8K
Chief Executive Officer of Guangdong Division...
Total Annual Compensation: $259.6K
Chief Executive Officer of Beijing Division
Total Annual Compensation: $140.6K
Chief Technology Officer
Total Annual Compensation: $135.8K
Compensation as of Fiscal Year 2015.

china cord blood corp (CO) Key Developments

China Cord Blood Corporation Reports Consolidated Unaudited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

China Cord Blood Corporation reported consolidated unaudited earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, the company reported revenues of RMB 162,994,000 compared with RMB 151,915,000 for the same period last year. Operating income was RMB 49,523,000 compared with RMB 64,013,000 for the same period last year. Interest income was RMB 4,708,000 compared with RMB 4,615,000 for the same period last year. Income before income tax was RMB 29,012,000 compared with RMB 52,532,000 for the same period last year. Net income attributable to company shareholders was RMB 16,923,000 or RMB 0.23 diluted per share compared with RMB 39,539,000 or RMB 0.46 diluted per share for the same period last year. Non-GAAP operating income was RMB 76,585,000 compared with RMB 73,821,000 for the same period last year. Operating income was mainly caused by higher depreciation expense due to the completion of the new facilities and the recognition of share-based compensation expense related to the restricted share units (RSUs) granted. Operating cash flow for the quarter was RMB 146,443,000 compared with RMB 137,399,000 for the same period last year. For the full year, the company reported revenues of RMB 635,122,000 compared with RMB 572,857,000 for the same period last year. Operating income was RMB 234,996,000 compared with RMB 231,926,000 for the same period last year. Interest income was RMB 18,252,000 compared with RMB 16,870,000 for the same period last year. Income before income tax was RMB 155,120,000 compared with RMB 190,924,000 for the same period last year. Net income attributable to company shareholders was RMB 107,292,000 or RMB 1.36 diluted per share compared with RMB 131,903,000 or RMB 1.60 diluted per share for the same period last year. Non-GAAP operating income was RMB 268,991,000 compared with RMB 12,355,000 for the same period last year. Operating cash flow increased by 11.0% to RMB 594,866,000 ($96.0 million) from RMB 536,015,000 in the prior year. The increase in revenue was largely attributable to the increase in storage fees related revenues.

China Cord Blood Corporation to Report Q4, 2015 Results on Jun 18, 2015

China Cord Blood Corporation announced that they will report Q4, 2015 results After-Market on Jun 18, 2015

China Cord Blood Corporation, Q4 2015 Earnings Call, Jun 19, 2015

China Cord Blood Corporation, Q4 2015 Earnings Call, Jun 19, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CO:US $5.54 USD +0.10

CO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Zhongyuan Union Cell & Gene Engineering Corp Ltd CNY79.34 CNY 0.00
View Industry Companies
 

Industry Analysis

CO

Industry Average

Valuation CO Industry Range
Price/Earnings 25.3x
Price/Sales 4.0x
Price/Book 1.6x
Price/Cash Flow 23.4x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA CORD BLOOD CORP, please visit www.chinacordbloodcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.